Skip to main content
AmigoFish

Episode 433: Cancer Treatments for Noncancer Indications: Chemotherapy/Immunotherapy

From The ONS Podcast · · 33 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

"Unlike our cancer indications where we use these medications often to activate the immune system to target cancerous cells, in noncancer indications, the goal is really to either suppress an overactive immune or inflammatory cells or modulate the immune system. Immune modulation by use of chemotherapy and immunotherapy can help reduce abnormal inflammation, decrease autoantibody production, and also can alter T-cell and B-cell activity," ONS member Kelsey Miller, MSN, RN, AGCNS-BC, OCN®, clinical nurse specialist in oncology and infusion therapy at Reading Hospital in West Reading, PA, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about chemotherapy and immunotherapy for noncancer indications.

Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod

Licensed under Creative Commons by Attribution 3.0

Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by September 18, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Learning outcome: Learners will report an increase in knowledge related to the use of anticancer therapies for noncancer indications.

Episode Notes

- Complete this evaluation for free NCPD.

- ONS Podcast™ episodes:

- Pharmacology 101 series

- Episode 152: Administer Rituximab Immunotherapy With Confidence

- ONS Voice articles:

- JAK1 Inhibitor Quickly Relieves ICI-Related Dermatitis

- Oncology Drug Reference Sheet: Cyclophosphamide

- Oncology Drug Reference Sheet: Methotrexate

- What Oncology Nurses Need to Know About Arboviral Disease in Patients Receiving B-Cell–Depleting or –Modulating Therapies

- ONS books:

- Access Device Guidelines: Recommendations for Nursing Practice and Education (fourth edition)

- Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition)

- Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition)

- Clinical Journal of Oncology Nursing article: Early Recognition and Response of Chemotherapy-Induced Hypersensitivity Reactions: A Nursing Discussion

- ONS courses:

- ONS Fundamentals of Chemotherapy and Immunotherapy Administration™

- Safe Handling Basics

- Vascular Access Devices

- ONS Huddle Cards:

- Anaphylaxis

- Monoclonal Antibodies

- ONS position statement: Education of the Nurse Who Administers and Cares for the Individual Receiving Antineoplastic Therapies

- American Academy of Neurology: Practice Guideline Recommendations: Disease-Modifying Therapies for Adults With Multiple Sclerosis

- American College of Rheumatology: Treatments

- National Multiple Sclerosis Society:

- Infused therapies

- Injectable therapies

- Medications Used Off-Label

- NCODA Patient Education Sheets (https://patienteducationsheets.com/)

To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/).

To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library.

To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.

Highlights From This Episode

"The most common immunotherapy agent that's well known to both oncology and other autoimmune disorders is rituximab. And that is used for rheumatoid arthritis, granulomatous, and antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. And then it also has many off-label indications for other autoimmune disorders, such as lupus and multiple sclerosis. It's also used in immune thrombocytopenia and Sjogren's condition." TS 3:28

"Two common chemotherapy agents that come to mind that are used in…

Back to The ONS Podcast · Report a problem